Cyber Space Agenda 2020
It’s only at Intelligent Health AI where you will find unlimited content. In partnership with our sponsors, we have created the Cyber Space agenda – extra content for you at set times, because we know your hunger for knowledge has to be fed and has to be punctual!
Running in Central European Time
Watch live demos and presentations and take part in discussions streamed from all corners of the world. Feed you mind with unlimited content!
DAY ONE – Wednesday 9th September 2020
| TIME | TITLE | CYBERSPACE |
| 08:30 –
08:50 |
Compound screening using graph convolutional networks – COVID-19 case study
Yujiro Otsuka, Representative Managing Partner, Plusman |
Plusman |
| 09:30 – 10:30 | Meet the Fondation Botnar team – come with your questions
Kiara Marvuglio, Engagement and Communications Manager, Fondation Botnar |
Fondation Botnar |
| 11:00 – 11:20 | A guide to selecting your first AI project
Kamil Zalewski, AI practice lead, Unit8 |
UNIT8 |
| 11:20 – 11:40 | Accelerating innovation from clinical trials to clinical practice with Holmusk real world data analytics
Stefan Suter, Head Europe, Holmusk Dr. Jordan Abdi, Strategy and Business Development Lead, Holmusk Subina Surendran, Director of Life Sciences Partnerships, Holmusk Moderator: Dr. Alex Knight, Project Manager, Holmusk |
Holmusk |
| 11:20 – 11:40 | Combination Products according to the European Medical Device Regulation 2017/745 Article 117 (live)
Adrian Gammeter, Senior Consultant, Confinis |
Confinis |
| 11:20 – 11:40 | AI for finding More Patients including undiagnosed ones for Commercial and Research in Industry
Dr. Vibhor Gupta, Director and Founder, Pangaea Data |
Pangaea Data |
| 11:30 – 11:40 | Counterfeit medicines, medical products and COVID-19
Tuomas Kannas, Co-founder and SVP, TrueMed |
TrueMed |
| 11:45 – 12:00 | The UK’s AI healthcare expertise: Greater London
Sura Hussein, Senior Inward Investment Manager Innovation & Life Sciences, London&Partners London has all of the ingredients of a dynamic and innovative life sciences ecosystem: world-class higher education institutions, leading specialist and teaching hospitals, a large and diverse population, and a vibrant community of life science, digital and supply chain companies. Sura Hussein of London & Partners will showcase the region’s expertise for example in AI in cancer research, give an outline of future plans in development, and describe how L&P can help companies be part of it all. |
UK’s Department for International Trade |
| 12:05 – 12:20 | UK Case Study: MedCity, AI in imaging and diagnostics
Phil Jackson, Head of International and Cluster Development, MedCity MedCity is the cluster organisation for the world-leading health and life sciences sector in London and the Greater South East of England, set up in 2014 by the Mayor of London and the region’s Academic Health Science Centres to drive growth and investment in the sector. Phil Jackson will present specifically on the use of AI in imaging and diagnostics within the MedCity cluster, and describe the ways in which the cluster can support digital health companies. |
UK’s Department for International Trade |
| 12:15 – 12:45 | Regulatory all you can eat 1: open live Q&A session
Martina Coscia, Consultant, Confinis Andrea Biasiucci, Senior Consultant and Clinical Evaluation, Digital Health and Active Implantable Cluster Leader, Confinis |
Confinis |
| 12:30 –
12:50 |
Lung nodule management and response evaluation of molecular targeted agents for non-small cell lung cancer by 3D U-net deep learning model
Yusuke Nakamura, Managing Partner, Plusman |
Plusman |
| 13:20 –
13:40 |
Democratizing access to mental health data and analytics in a single platform: NeuroBlu
Sankha S. Mukherjee, Ph.D., Senior Data Scientist, Holmusk Rajagopalan Ramaswamy, Ph.D., Senior Data Scientist, Holmusk Moderator: Dr Rashmi Patel MD PhD, CMO (Europe), Holmusk |
Holmusk |
| 13:20 –
13:40 |
AI to Extract Intelligence from Doctors Notes
Dr. Julia Ive, Head of NLP, Pangaea Data |
Pangaea Data |
| 14:00 – 14:30 | Extended Q&A – USE CASE 1: Privacy preserving federated learning for AI in healthcare with an application to semantic segmentation of computed tomography (CT) scans of vertebrae
Dr. Gabriel Krummenacher, Team Lead Data Science, Zuehlke Group Tomas Dikk, Lead Data Science, Zuehlke Group Roland Herzog, Head Technology Transfer, AO Foundation |
Zühlke |
| 14:05 – 14:20 | Digitize health care value chain
Florent Bouguin, CTO, Optel Group |
Optel |
| 14:00 – 14:25 | Chronolife: Innovative Digital Health solutions paired with Predictive algorithm
Nicolas Wojciechowski, Sales Country Manager, Chronolife |
Chronolife |
| 14:30 – 14:50 | GenAIz Overview
Raagi Pandya, Director, Product & Development, GenAIz |
GenAIz |
| 14:40 – 15:40 | Meet AlpVision – come with questions!
Dr. Fred Jordan, CEO, AlpVision |
AlpVision |
| 15:00 – 15:15 | The UK’s AI healthcare expertise: Greater Manchester
Catherine Davidson, Head of Business Development, MIDAS The Greater Manchester area is one of the UK’s most exciting hubs of innovation for digital health, and offers particular expertise in health analytics and medtech. Catherine Davidson of MIDAS, Manchester’s Investment Agency, will highlight opportunities for companies active in AI in healthcare, and describe ways MIDAS can support those companies in the region. |
UK’s Department for International Trade |
| 15:20 – 15:35 | UK case study: Salford Royal NHS Foundation Trust’s Digital Control Centre
James Ritchie, CCIO, DCC Programme Lead Salford Royal NHS Trust is a leading e-enabled NHS trust in England. The Digital Control Centre programme, launched in 2019, is a 10 year project to revolutionise the organisation of care across its acute and integrated services. Jim Ritchie, consultant kidney doctor and lead for the DCC programme, will describe the scope and initial delivery of this major transformation programme. |
UK’s Department for International Trade |
| 15:30 – 15:40 | Live demo of confinis’ Atlassian-based paperless electronic Quality Management System (live)
Stefano Adami, Competence Cluster Lead & Senior Consultant, Confinis |
Confinis |
| 15:30 – 15:50 | Value of Causal AI in Cardiovascular and Chronic Kidney Disease
Dr. Abhijit Ghosh, Senior Data Scientist, Holmusk Subina Surendran, Director of Life Sciences Partnerships, Holmusk Armita Afsharinejad, Associate Director Data Science, Novartis Moderator: Dr. Alex Knight, Project Manager, Holmusk |
Holmusk |
| 15:40 – 15:50 | Counterfeit medicines, medical products and COVID-19
Tuomas Kannas, Co-founder and SVP, TrueMed |
TrueMed |
| 15:40 – 15:50 | New Career Opportunities in AI and Healthcare with serial entrepreneurs
Mr. Jingqing Zhang, Head of AI, Pangaea Data Dr. Zhihua Wang, Head of Product, Pangaea Data |
Pangaea Data |
| 16:05 – 16:15 | UK Company Pitch: Ampersand Health
Aahuti Rai, Chief Strategy & Growth Officer Ampersand Health is creating the first clinically-validated, behavioural science-based digital therapeutics for inflammatory conditions. Their apps use behavioural- and data-science to support improvements in sleep, mental health and adherence for people living with an inflammatory condition. Ampersand Health is recognised in the Digital Health Global 100, and has won an HSJ Award, the NHS Ideas Lab, the NHS Hackfest and competitive grants from government and industry. |
UK’s Department for International Trade |
| 17:00 – 17:20 | FDA’s Regulatory Oversight on AI and Digital Health (live)
Viky Verna, Co-Founder and VP, Confinis |
Confinis |
DAY 2 – Thursday 10th September 2020
| TIME | TITLE | CYBERSPACE |
| 08:30 – 08:50 | Compound screening using graph convolutional networks – COVID-19 case study
Yujiro Otsuka, Representative Managing Partner, Plusman |
Plusman |
| 08:30 – 09:00 | Regulatory all you can eat 1: open live Q&A session
Martina Coscia, Consultant, Confinis Andrea Biasiucci, Senior Consultant and Clinical Evaluation, Digital Health and Active Implantable Cluster Leader, Confinis |
Confinis |
| 09:00 – 09:20 | Lung nodule management and response evaluation of molecular targeted agents for non-small cell lung cancer by 3D U-net deep learning model
Yusuke Nakamura, Managing Partner, Plusman |
Plusman |
| 09:00 – 10:00 | Meet AlpVision – come with your questions!
Dr. Martin Kutter, President, AlpVision |
AlpVision |
| 09:30 – 09:40 | UK Company Pitch: Kraydel
Amer Fasihi, CEO & Co-Founder, Kraydel Kraydel, the leader in Agetech, improves the quality of life and independence of their users, by tackling social isolation, supporting a proactive approach to well-being and resilience, and through their platform, enabling the provision of services to address digital exclusion. |
UK’s Department for International Trade |
| 09:50 – 10:00 | UK Company Pitch: DDM (Diabetes Digital Media)
Arjun Panesar, CEO DDM provide evidence-based digital therapeutics (apps) that engage patients and improve clinically health outcomes in 7 markets and 6 languages. Outcomes include weight loss, improved blood glucose control, type 2 diabetes remission, and reduction in symptoms of anxiety, stress and depression. Their award-winning solutions are available on a range of platforms including iOS, Android, Apple and Android watch, Amazon Alexa and in VR on Oculus Rift and HTC Vive. |
UK’s Department for International Trade |
| 10:10 – 10:20 | UK Company Pitch: Cievert
Alex Blakoe, COO, Cievert Cievert has developed technology to enhance a wide variety of clinical disciplines, from referral management to patient follow-up and consultations. The rich data accumulated is being used to develop an AI-enabled platform that stratifies risk, detecting conditions earlier. By applying machine learning to clinical pathways, this platform can also continuously inform and thus improve treatment using real world data, optimising and personalising healthcare. |
UK’s Department for International Trade |
| 10:30 – 10:40 | UK Company Pitch: Farmatrust
Raja Sharif, CEO FarmaTrust provides future-proof blockchain and AI based provenance systems for the pharmaceutical and healthcare sector. FarmaTrust digital solutions and services create efficiencies, accountability and transparency for supply chains, ease the burden of compliance requirements, reduce costs and eliminate counterfeit or substandard products. |
UK’s Department for International Trade |
| 10:55 – 11:15 | Jumping the innovation chasm – from AI-lab to diagnostics product in 6 months.
Boris Langer, Senior Business Solution Manager, Zühlke There are plenty of ideas on how to use machine learning for a better health system. Only few of them make it to the market. Many brilliant prototypes fall prey to discordant stakeholders, ambitious quality requirements or strict data protection policies. Together with one of our customers we managed to get from a research prototype to a fully FDA compliant software application in only 6 months. In this presentation we want to outline the main obstacles we encountered and how we overcame them. |
Zühlke |
| 10:55 – 11:15 | Introduction on cybersecurity within the European Medical Device Regulation (live)
Martina Coscia, Consultant, Confinis |
Confinis |
| 10:55 – 11:15 | AI to Extract Intelligence from Doctors Notes
Dr. Julia Ive, Head of NLP, Pangaea Data |
Pangaea Data |
| 11:00 – 11:20 | A guide to selecting your first AI project
Kamil Zalewski, AI practice lead, Unit8 |
UNIT8 |
| 11:00 – 11:25 | Chronolife: Innovative Digital Health solutions paired with Predictive algorithm
Nicolas Wojciechowski, Sales Country Manager, Chronolife |
Chronolife |
| 11:00 – 12:00 | Meet the Fondation Botnar team – come with your questions
Kiara Marvuglio, Engagement and Communications Manager, Fondation Botnar |
Fondation Botnar |
| 11:25 – 11:45 | Real world data enrichment using Natural Language Processing and Advanced Predictive Analytics
Joydeep Sarkar, Chief Analytics Officer, Holmusk Jesisca Tandi, Data Scientist, Holmusk Moderator: Dr Rashmi Patel MD PhD, CMO (Europe), Holmusk |
Holmusk |
| 12:25 – 12:40 | The UK’s AI healthcare expertise: AI in healthy ageing
Julie Taylor, Ageing Society Specialist, UK’s Department for International Trade The UK’s Industrial Strategy sets out four Grand Challenges to put the UK at the forefront of industries of the future, focused on global trends which will transform our future and include both the Ageing Society and AI. The UK is at the forefront of ageing research and development, for example the UK Dementia Research Institute is working to harness recent advances in artificial intelligence, engineering, robotics and sleep science to create new technologies that will deliver the highest quality dementia care in the home. The UK offers an unique opportunity for companies with innovative solutions for the ageing society to test, develop and grow. |
UK’s Department for International Trade |
| 12:45 – 13:00 | UK case study: King’s College Longevity AI Consortium
Richard Siow, Director Ageing Research, (ARK) King’s College London Use of artificial intelligence within longevity and ageing research is rapidly increasing in both academia and industry. To implement the latest AI advances and accelerate innovation and technology transfer, Ageing Research at King’s (ARK) has partnered with academic, charity, industry and policy partners to establish UK’s first Longevity AI Consortium (LAIC) at King’s College London. Advanced machine learning will be developed to provide robust biomarkers of longevity for diverse data types. |
UK’s Department for International Trade |
| 13:00 – 13:25 | How to overcome Regulatory and Clinical Affairs Challenges in Digital Health and AI (on-demand)
Beat U. Steffen, CEO, Confinis |
Confinis |
| 13:00 – 13:25 | Technical Demo
Mr. Jingqing Zhang, Head of AI, Pangaea Data Dr. Zhihua Wang, Head of Product, Pangaea Data |
Pangaea Data |
| 13:20 – 13:50 | Leveraging Causal AI to enhance Alzheimer’s Disease trials
Joydeep Sarkar, Chief Analytics Officer, Holmusk Pascale Bouchard Cannon, Ph.D., Senior Data Scientist, Holmusk Prof. Andreas U. Monsch, PhD, Head Memory Clinic, University Basel Department of Geriatric Medicine Felix Platter |
Holmusk |
| 14:00 – 14:15 | Picomole Overview
Stehen Graham, CEO, Picomole |
Invest in Canada |
| 14:15 – 14:30 | Digitize Value Chain to Enable Personalized Medicine
Florent Bouguin, Vice President, Chief Technology Officer, Optel Group |
Invest in Canada |
| 14:15 – 14:40 | The Anatomy of Data-Driven Companies
Gian-Marco Baschera, Principal Consultant, Zühlke Data-driven companies have come a long way in the past decade. What is it that distinguishes high-performing organisations and enables them to relentlessly create sustainable value from their data? What are their key capabilities and where will this journey lead to in the coming years? Our speaker, Gian-Marco Baschera, highlights technological and organisational success factors, best practices and emerging trends that set up companies onto the path to reap the benefits of being truly data-driven. |
Zühlke |
| 14:15 – 14:40 | Clinical evidence and Digital Health (live)
Andrea Biasiucci, Senior Consultant and Clinical Evaluation, Digital Health and Active Implantable Cluster Leader, Confinis |
Confinis |
| 14:15 – 14:40 | Making the Most from Healthcare data to Accelerate Scientific Research
Dr. Vibhor Gupta, Director and Founder, Pangaea Data |
Pangaea Data |
| 14:30 – 14:45 | Accelerating Drug Discovery with Cyclica’s AI-Augmented Platform
Vern De Biasi, Global Head of Strategic Partnerships, Cyclica |
Invest in Canada |
| 14:45- 15:00 | ProteinQure – Introduction and case study on designing de-novo binders for intracellular targets
Lucas Siow, Co-Founder & CEO, Proteinequer |
Invest in Canada |
| 15:00 – 15:15 | emrchiver – A platform for migrating & enabling data from healthcare legacy systems.
Michael Lagowski, VP, Strategy & Product Development, Translucent Computing |
Invest in Canada |
| 15:00 – 16:00 | Meet AlpVision – come with your questions!
Dr. Ewelina Kurtys, Scientist, AlpVision |
AlpVision |
| 15:15 – 15:30 | Automating your Covid-19 Absence Management Efforts
Andrew Heneghan, EU Sales Consultant, Andgo |
Invest in Canada |
| 15:30 – 15:45 | Digital health solutions that help improve the lives of specialty patients and vulnerable populations with high unmet needs.
J. Manasse Theagene, CEO, 360Medlink |
Invest in Canada |
| 15:45 – 16:00 | Ultrasound + Artificial intelligence. Enabling the stethoscope of the 21st century.
David Quail, VP of Technology Commercialization, Medo.ai |
Invest in Canada |
| 16:00 – 16:15 | Virtual collaboration around the patient
Alexandra T. Greenhill MD, CEO / CHIEF MEDICAL OFFICER, Careteam |
Invest in Canada |
| 16:15 – 16:30 | The Power of Foresight
Amir Hayeri, CEO, bioconscious |
Invest in Canada |
| 16:30 – 16:45 | Maryam Sadeghi, CEO, MetaOptima | Invest in Canada |
| 16:30 – 16:50 | How to overcome Regulatory and Clinical Affairs Challenges in Digital Health and AI (on-demand)
Beat U. Steffen, CEO, Confinis |
Confinis |
| 16:45 – 17:00 | emtelligent – Transforming Healthcare with Medical NLP
Tim O’Connell, CEO, Emtelligent |
Invest in Canada |